The reductive metabolism of halothane was studied in 34 adult patients undergoing routine surgery. Reductive biotransformation of halothane was more extensive in females than males and was also enhanced in two patients treated preoperatively with phenytoin, an enzyme-inducing drug. Tobacco, ethanol and the patient's age, body weight and previous exposure to halothane did not influence reductive metabolism of halothane.
StierA., AlterH., HesslerO., RehderK.Urinary excretion of bromide in halothane anaesthesia. Anesth Analg1964; 43: 723–728.
2.
Van DykeR.A., ChenowethM.B., Van PoznakA.Metabolism of volatile anaesthetics — I: Conversion in vivo of several anaesthetics to 14CO2 and chloride. Biochem Pharmacol1964; 13: 1239–1247.
3.
SipesI.G., GandolfiA.J.Role of reactive intermediates in halothane associated liver injury. In: Biological Reactive Intermediates II, PartA., SnyderR., ParkeD.V., KocsisJ.J., JollowD.J., GibsonC.G., WitmerC.M. eds. Plenum Press, New York1982; pp. 603–608.
4.
CousinsM.J., SharpJ.H., GourlayG.K., AdamsJ.F., HaynesW.D., WhiteheadR.Hepatotoxicity and halothane metabolism in an animal model with application for human toxicity. Anaesth Intens Care1979; 7: 9–24.
5.
CousinsM.J., GourlayG.K., KnightsK.M., Hall P de laM., LunamC.A., O'BrienP.A randomized prospective controlled study of the metabolism and hepatotoxicity of halothane in humans. Anesth Analg1987; 66: 299–308.
6.
SatohH., FukudaU., AndersonD.K., FerransV.J., GilletteJ.R., PohlL.R.Immunological studies on the mechanism of halothane-induced hepatotoxicity: Immunohistochemical evidence of trifluoroacetylated hepatocytes. J Pharmacol Exp Ther1985; 223: 857–862.
7.
SatohH., GilletteJ.R., TakemuraT.. Investigation of the immunological basis of halothane-induced hepatotoxicity. In: Biological Reactive Intermediates III.KocsisJ.J., JollowD.J., WitmerC.M., NelsonJ.O., SnyderR. eds. Plenum Press, New York1986; pp. 657–673.
8.
PlummerJ.L., StevenI.M., CousinsM.J.Metabolism of halothane in children having repeated halothane anaesthetics. Anaesth Intens Care198715: 136–140.
9.
PollardJ.H.A Handbook of Numerical and Statistical Techniques.Cambridge University Press, Cambridge1979; pp. 37–38.
10.
FreundR.F., MintonP.D.Regression Methods. A Tool for Data Analysis.Marcel Dekker, New York1979; pp. 120–137.
11.
SpeegK.V., PatwardhanR.V., AvantG.R., MitchellM.C., SchenkerS.Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodents. Gastroenterology1982; 82: 89–96.
12.
ParkB.K., BreckenridgeA.M.Clinical implications of enzyme induction and enzyme inhibition. Clin Pharmacokin1981; 6: 1–24.
SiegersC-P, MackenrothT., WachterS., YounesM.Effects of thyroid dysfunction on the metabolism of halothane, enflurane and methoxyflurane in rats. Pharmacology1981; 22: 41–46.
15.
SharpJ.H., TrudellJ.R., CohenE.N.Volatile metabolites and decomposition products of halothane in man. Anesthesiology1979; 50: 2–8.
16.
GourlayG.K., AdamsJ.F., CousinsM.J., SharpJ.H.Time-course of formation of volatile reductive metabolites in humans and in an animal model. Br J Anaesth1980; 52: 331–336.
17.
MillerM., CosgriffJ., KwongT., MorkenD.A.Influence of phenytoin on theophylline clearance. Clin Pharmacol Ther1983; 35: 666–669.
18.
JennerM.A., PlummerJ.L., CousinsM.J.Influence of phenytoin and pregnenolone-16-alpha-carbonitrile on halothane metabolism and hepatotoxicity (Abstract). Clin Exp Pharmacol Physiol1987; Suppl 10: 14.
19.
NomuraF., HatanoH., OhnishiK., AkikusaB., OkudaK.Effects of anticonvulsant agents on halothane-induced liver injury in human subjects and experimental animals. Hepatology1986; 6: 952–956.
20.
CascorbiH.F., VessellE.S., BlakeD.A., HelrichM.Halothane biotransformation in man. Ann NY Acad Sci1981; 179: 244–248.
21.
HoftR.H., BunkerJ.P., GoodmanH.I., GregoryP.B.Halothane hepatitis in three pairs of closely related women. N Engl J Med1981; 304: 1023–1024.
22.
OtsukaS., YamamotoM., KasuyaS., YamamotoY., YoshidaT.O., AkazaT.HLA antigens in patients with unexplained hepatitis following halothane anaesthesia. Acta Anaesthesiol Scand1985; 29: 497–501.
23.
FarrellG., PrendergastD., MurrayM.Halothane hepatitis. Detection of a constitutional susceptibility factor. N Engl J Med1985; 313: 1310–1314.
24.
EkstrandJ., AlvanG., BoreusL.O., NorlinA.Pharmacokinetics of fluoride in man after single and multiple oral doses. Eur J Clin Pharmacol1977; 21: 311–317.
25.
EgerE.I., LarsonCPJr.. Anaesthetic solubility in blood and tissues: Values and significance. Br J Anaesth1964; 36: 140–149.
